Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVolitionRx Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.11 | -$0.09 | -$0.10 |
| Q2 2024 | 1 | -$0.10 | -$0.09 | -$0.09 |
| Q3 2024 | 1 | -$0.08 | -$0.07 | -$0.07 |
| Q4 2024 | 2 | -$0.06 | -$0.05 | -$0.06 |
| Q1 2025 | 1 | -$0.05 | -$0.04 | -$0.05 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q1 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q2 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q1 2027 | 1 | $0.35 | $0.40 | $0.38 |
| Q2 2027 | 1 | $0.35 | $0.40 | $0.38 |
| Q3 2027 | 1 | $0.35 | $0.41 | $0.39 |
| Q4 2027 | 1 | $0.38 | $0.44 | $0.41 |
| Q1 2028 | 1 | $0.47 | $0.55 | $0.52 |
| Q2 2028 | 1 | $0.47 | $0.55 | $0.52 |
| Q3 2028 | 1 | $0.48 | $0.56 | $0.53 |
| Q4 2028 | 1 | $0.51 | $0.59 | $0.56 |
VolitionRx Limited Earnings Date And Information
VolitionRx Limited last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.08 earnings per share for the quarter, topping analysts' consensus estimates of $-0.09 by $0.01. The company had revenue of 474,522 for the quarter and had revenue of 775,302 for the year. VolitionRx Limited has generated $-1 earnings per share over the last year ($-0.5 diluted earnings per share) and currently has a price-to-earnings ratio of -1.86. VolitionRx Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
VolitionRx Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.07 | $652,000 | $474,522 | ||
| 08/14/2024 | Q2 2024 | -$0.09 | -$0.08 | 0.01 | $462,978 | $395,797 |
| 05/13/2024 | Q1 2024 | -$0.11 | -$0.10 | 0.01 | $171,535 | |
| 03/25/2024 | Q4 2023 | -$0.11 | -$0.11 | 0 | $243,973 | |
| 11/14/2023 | Q3 2023 | -$0.12 | -$0.11 | 0.01 | $356,600 | $165,211 |
| 08/14/2023 | Q2 2023 | -$0.13 | -$0.14 | -0.01 | $271,250 | $216,310 |
| 05/10/2023 | Q1 2023 | -$0.14 | -$0.15 | -0.01 | $149,808 | |
| 03/15/2023 | Q4 2022 | -$0.15 | -$0.13 | 0.02 | $119,715 | |
| 11/14/2022 | Q3 2022 | -$0.15 | -$0.14 | 0.01 | $94,335 | $32,714 |
| 08/10/2022 | Q2 2022 | -$0.15 | -$0.14 | 0.01 | $110,750 | $39,752 |
| 05/11/2022 | Q1 2022 | -$0.01 | -$0.14 | -0.13 | $114,211 | |
| 03/30/2022 | Q4 2021 | -$0.14 | -$0.15 | -0.01 | $14,240 | |
| 11/10/2021 | Q3 2021 | -$0.10 | -$0.13 | -0.03 | $143,600 | $25,483 |
| 08/11/2021 | Q2 2021 | -$0.12 | -$0.10 | 0.02 | $74,250 | $24,782 |
| 05/11/2021 | Q1 2021 | -$0.12 | -$0.12 | 0 | $25,530 | |
| 03/22/2021 | Q4 2020 | -$0.10 | -$0.11 | -0.01 | $7,120 | |
| 11/12/2020 | Q3 2020 | -$0.11 | -$0.09 | 0.02 | $2,500 | $575 |
| 08/13/2020 | Q2 2020 | -$0.13 | -$0.12 | 0.01 | $30,000 | $5,194 |
| 05/07/2020 | Q1 2020 | -$0.10 | -$0.14 | -0.04 | $544 | |
| 02/20/2020 | Q4 2019 | -$0.11 | -$0.09 | 0.02 | $0 |
VolitionRx Limited Earnings: FAQ's
When is VolitionRx Limited's earnings date?
VolitionRx Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
Did VolitionRx Limited beat their earnings estimates last
quarter?
In the previous quarter, VolitionRx Limited (:VNRX) reported $-0.08 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.09 by $0.01.
How can I listen to VolitionRx Limited's earnings conference
call?
The conference call for VolitionRx Limited's latest earnings report can be listened to online.
How can I read VolitionRx Limited's conference call transcript?
The conference call transcript for VolitionRx Limited's latest earnings report can be read online.
How much revenue does VolitionRx Limited generate each year?
VolitionRx Limited (:VNRX) has a recorded annual revenue of $775,302.
How much profit does VolitionRx Limited generate each year?
VolitionRx Limited (:VNRX) has a recorded net income of $775,302. VolitionRx Limited has generated $-0.5 earnings per share over the last four quarters.
What is VolitionRx Limited's price-to-earnings ratio?
VolitionRx Limited (:VNRX) has a price-to-earnings ratio of -1.86 and price/earnings-to-growth ratio is -0.19.